Evidence map›Paper›PMID 41054783›Full record

ArticleClinical case reports2025

Management of Recurrent Metastasis of Renal Cell Carcinoma to the Parotid Gland After Nephrectomy.

Kathryn Collins, Emily Cushing, Alex Ellerhorst, Christopher Selinsky

Abstract read
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kathryn CollinsDepartment of Otolaryngology/Head and Neck Surgery OhioHealth Doctors Hospital Columbus Ohio USA.ORCID https://orcid.org/0000-0001-6977-2007
Emily CushingOhio University Heritage College of Osteopathic Medicine Dublin Ohio USA.
Alex EllerhorstDepartment of Otolaryngologayl OhioHealth Doctors Hospital Columbus Ohio USA.
Christopher SelinskyDepartment of Otolaryngology/Head and Neck Surgery OhioHealth Doctors Hospital Columbus Ohio USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal cell carcinoma accounts for 90% of malignant renal tumors, with common metastases to the lungs, bones, and brain. Head and neck metastases are uncommon, and the parotid gland is an exceedingly rare site (0.5%). Recurrent metastasis to bilateral parotid glands has been reported in the literature, but recurrent metastasis to the ipsilateral gland has not. This is a case about a 69-year-old female who presented to our clinic with the chief complaint of a slowly enlarging left neck mass. She had a history of clear cell renal cell carcinoma treated with nephrectomy 15 years prior. An MRI reviewed from 2 years earlier incidentally noted a left parotid tail lesion that had not been evaluated. CT and fine needle aspiration biopsy raised concern for malignancy. The patient underwent superficial parotidectomy, which confirmed metastatic clear cell renal cell carcinoma. Surveillance imaging was recommended but not completed. Two years later, she re-presented with recurrence in the same parotid gland. A multidisciplinary tumor board recommended surgery with preservation of the facial nerve, followed by radiation and immunotherapy. This case underscores the unpredictable metastatic pattern of renal cell carcinoma and the importance of long-term surveillance even beyond recommended guidelines. Clinicians should maintain a high index of suspicion for metastatic renal cell carcinoma in patients with a history of nephrectomy presenting with a parotid mass, given the potential for late recurrence.

Indexed as

non‐primary parotid malignancyrecurrent metastases after nephrectomyrenal cell carcinomasame sided recurrence

Identifiers

PMID41054783
PMCPMC12496566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.